Alphatec Holdings (ATEC) Total Non-Current Liabilities (2010 - 2026)
Alphatec Holdings (ATEC) reported Total Non-Current Liabilities of $789.4 million for Q1 2026, up 16.29% on a YoY basis from $678.8 million in Q1 2025, and up 1.14% sequentially from $780.5 million in Q4 2025.
Alphatec Holdings (ATEC) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Total Non-Current Liabilities data on file, last reported at $789.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 16.29% year-over-year to $789.4 million; the trailing twelve-month figure through Mar 2026 stood at $789.4 million (up 16.29% YoY), and the FY2025 full-year result was $780.5 million, up 2.12% from the prior year.
- Total Non-Current Liabilities advanced to $789.4 million in Q1 2026, from $780.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $794.0 million in Q4 2023 to a low of $496.2 million in Q2 2022.
- A 5-year average of $675.7 million and a median of $733.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities retreated 13.69% in 2022 and jumped 54.34% in 2023, its largest moves.
- Tracing ATEC's Total Non-Current Liabilities over 5 years: stood at $514.4 million in 2022, then jumped by 54.34% to $794.0 million in 2023, then retreated by 3.74% to $764.3 million in 2024, then gained by 2.12% to $780.5 million in 2025, then gained by 1.14% to $789.4 million in 2026.
- Business Quant data shows ATEC's Total Non-Current Liabilities at $789.4 million in Q1 2026, $780.5 million in Q4 2025, and $776.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 789.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 789.39 Mn |
| Dec 31, 2025 | 780.47 Mn |
| Sep 30, 2025 | 775.98 Mn |
| Jun 30, 2025 | 779.75 Mn |
| Mar 31, 2025 | 678.81 Mn |
| Dec 31, 2024 | 764.29 Mn |
| Sep 30, 2024 | 733.54 Mn |
| Jun 30, 2024 | 756.67 Mn |
| Mar 31, 2024 | 763.40 Mn |
| Dec 31, 2023 | 794.01 Mn |
| Sep 30, 2023 | 658.60 Mn |
| Jun 30, 2023 | 614.83 Mn |
| Mar 31, 2023 | 553.51 Mn |
| Dec 31, 2022 | 514.44 Mn |
| Sep 30, 2022 | 501.80 Mn |
| Jun 30, 2022 | 496.19 Mn |
| Mar 31, 2022 | 532.06 Mn |
| Dec 31, 2021 | 570.53 Mn |
| Sep 30, 2021 | 581.36 Mn |
| Jun 30, 2021 | 437.68 Mn |